Global Complement-dependent Cytotoxicity Testing Services Market Research Report 2025

Publication ID:

PB504260336

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Complement-dependent Cytotoxicity Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Complement-dependent cytotoxicity assay (CDC) is an in vitro cell-based assay used to evaluate the cytotoxic ability of antibodies against target cells. CDC is based on the activation of the complement system and the formation of the membrane attack complex (MAC). In the CDC assay, target cells and antibodies are mixed, and then complement is added. Complement activation leads to the formation of MAC, resulting in the death of target cells. By measuring the survival rate of target cells or the release of molecules that represent cell death, the cytotoxic ability of the antibody can be evaluated. CDC is commonly used in the research and development of antibody drugs, vaccines, and immunotherapies, as well as in the evaluation of the efficacy of these treatments.
North American market for Complement-dependent Cytotoxicity Testing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Complement-dependent Cytotoxicity Testing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Complement-dependent Cytotoxicity Testing Services in Biopharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Complement-dependent Cytotoxicity Testing Services include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent, Sartorius, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Complement-dependent Cytotoxicity Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement-dependent Cytotoxicity Testing Services.
The Complement-dependent Cytotoxicity Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Complement-dependent Cytotoxicity Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement-dependent Cytotoxicity Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement-dependent Cytotoxicity Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement-dependent Cytotoxicity Testing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Common Type
1.2.3 High Throughput Type
1.3 Market by Application
1.3.1 Global Complement-dependent Cytotoxicity Testing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceuticals
1.3.3 Medical Diagnosis
1.3.4 Cell Engineering
1.3.5 Medical Treatment
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement-dependent Cytotoxicity Testing Services Market Perspective (2020-2031)
2.2 Global Complement-dependent Cytotoxicity Testing Services Growth Trends by Region
2.2.1 Global Complement-dependent Cytotoxicity Testing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Complement-dependent Cytotoxicity Testing Services Historic Market Size by Region (2020-2025)
2.2.3 Complement-dependent Cytotoxicity Testing Services Forecasted Market Size by Region (2026-2031)
2.3 Complement-dependent Cytotoxicity Testing Services Market Dynamics
2.3.1 Complement-dependent Cytotoxicity Testing Services Industry Trends
2.3.2 Complement-dependent Cytotoxicity Testing Services Market Drivers
2.3.3 Complement-dependent Cytotoxicity Testing Services Market Challenges
2.3.4 Complement-dependent Cytotoxicity Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement-dependent Cytotoxicity Testing Services Players by Revenue
3.1.1 Global Top Complement-dependent Cytotoxicity Testing Services Players by Revenue (2020-2025)
3.1.2 Global Complement-dependent Cytotoxicity Testing Services Revenue Market Share by Players (2020-2025)
3.2 Global Complement-dependent Cytotoxicity Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Complement-dependent Cytotoxicity Testing Services Revenue
3.4 Global Complement-dependent Cytotoxicity Testing Services Market Concentration Ratio
3.4.1 Global Complement-dependent Cytotoxicity Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement-dependent Cytotoxicity Testing Services Revenue in 2024
3.5 Global Key Players of Complement-dependent Cytotoxicity Testing Services Head office and Area Served
3.6 Global Key Players of Complement-dependent Cytotoxicity Testing Services, Product and Application
3.7 Global Key Players of Complement-dependent Cytotoxicity Testing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement-dependent Cytotoxicity Testing Services Breakdown Data by Type
4.1 Global Complement-dependent Cytotoxicity Testing Services Historic Market Size by Type (2020-2025)
4.2 Global Complement-dependent Cytotoxicity Testing Services Forecasted Market Size by Type (2026-2031)
5 Complement-dependent Cytotoxicity Testing Services Breakdown Data by Application
5.1 Global Complement-dependent Cytotoxicity Testing Services Historic Market Size by Application (2020-2025)
5.2 Global Complement-dependent Cytotoxicity Testing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Complement-dependent Cytotoxicity Testing Services Market Size (2020-2031)
6.2 North America Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2020-2025)
6.4 North America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Complement-dependent Cytotoxicity Testing Services Market Size (2020-2031)
7.2 Europe Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Complement-dependent Cytotoxicity Testing Services Market Size by Country (2020-2025)
7.4 Europe Complement-dependent Cytotoxicity Testing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Size (2020-2031)
8.2 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Complement-dependent Cytotoxicity Testing Services Market Size (2020-2031)
9.2 Latin America Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2020-2025)
9.4 Latin America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Size (2020-2031)
10.2 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Details
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Complement-dependent Cytotoxicity Testing Services Introduction
11.1.4 Creative Biolabs Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.1.5 Creative Biolabs Recent Development
11.2 iQ Biosciences
11.2.1 iQ Biosciences Company Details
11.2.2 iQ Biosciences Business Overview
11.2.3 iQ Biosciences Complement-dependent Cytotoxicity Testing Services Introduction
11.2.4 iQ Biosciences Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.2.5 iQ Biosciences Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Details
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Complement-dependent Cytotoxicity Testing Services Introduction
11.3.4 Horizon Discovery Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.3.5 Horizon Discovery Recent Development
11.4 Sino Biological, Inc.
11.4.1 Sino Biological, Inc. Company Details
11.4.2 Sino Biological, Inc. Business Overview
11.4.3 Sino Biological, Inc. Complement-dependent Cytotoxicity Testing Services Introduction
11.4.4 Sino Biological, Inc. Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.4.5 Sino Biological, Inc. Recent Development
11.5 GenScript ProBio
11.5.1 GenScript ProBio Company Details
11.5.2 GenScript ProBio Business Overview
11.5.3 GenScript ProBio Complement-dependent Cytotoxicity Testing Services Introduction
11.5.4 GenScript ProBio Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.5.5 GenScript ProBio Recent Development
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Complement-dependent Cytotoxicity Testing Services Introduction
11.6.4 Agilent Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.6.5 Agilent Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Complement-dependent Cytotoxicity Testing Services Introduction
11.7.4 Sartorius Revenue in Complement-dependent Cytotoxicity Testing Services Business (2020-2025)
11.7.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂